Sprint Analysts Recommendations and Consensus

S -- USA Stock  

USD 6.01  0.06  0.01%

The current analyst and expert consensus on Sprint is Sell with 12 hold recommendations. The current projected target price consensus is 6.81 with 13 analysts opinions. One of the most common ways Sprint analysists use to provide buy or sell recommendation to public are conference calls analysis and financial statements evaluations. Some experts can also talk to Sprint vendors, executives, and/or customers. Sprint recommendation module provides expert sentiment on the projected Sprint target price to derive its highest and lowest estimates based on target price standard deviation of 2.221. Also please take a look at Macroaxis Advice on Sprint to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

Sprint Target Price Consensus

Number of Opinions19
Lowered Outlook0
Raized Outlook0
Sell
Macroaxis Recommendation   Exposure   Valuation

Sprint Target Price Projection

Current Price

Sprint Market Quote

Low Price5.99Odds
High Price6.09Odds

6.01

Target Price

Analyst Consensus On Target Price

Low Estimate2.6Odds
High Estimate12.0Odds
Number of Analysts13
Standard Deviation2.221

6.809

Sprint Analysit Ratings

Average Consensus

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Current Thematic Trending

Real Goods Solar
Purchased few shares
Traded 3 days ago for 0.52
Pharmaceutical Products
Purchased over 90 shares
Traded 3 days ago for 0.13
Synergy Pharmaceuticals
Purchased few shares
Traded 3 days ago for 0.24
Vital Therapies
Purchased over 500 shares
Traded 3 days ago for 0.26
Pharmaceutical Products
Purchased over 100 shares
Traded 3 days ago for 0.13
Top Penny
Purchased over 100 shares
Traded 3 days ago for 0.8
Also please take a look at Macroaxis Advice on Sprint to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon. Please also try World Markets Correlation module to find global opportunities by holding instruments from different markets.
Search macroaxis.com